To evaluate the immunization of HBV vaccine with double dose comparing standard dose in chronic liver disease patients in Isfahan city 2010-2011
Not Applicable
- Conditions
- Chronic viral hepatitis C.Chronic viral hepatitis C
- Registration Number
- IRCT138902153873N1
- Lead Sponsor
- Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Age 18-65 years old, documented chronic HCV positive or cirrhosis
Exclusion criteria: previously HBV vaccination or HBV positive, alcoholic cirrhosis or hepatitis, immune deficiency, CKD with GFR<60ml/min/1.73m2 5, autoimmune hepatitis or cirrhosis
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anti HBS titer. Timepoint: Before & 1 month after intervention. Method of measurement: ELISA reader.
- Secondary Outcome Measures
Name Time Method